The CEO's $8.3M sale post-earnings is the largest insider sale at Hinge Health in the past 30 days. While the sales are pre-arranged and the company's fundamentals are strong (47% revenue growth, raised guidance), the timing and magnitude warrant monitoring for additional insider filings in the next 2-4 weeks. If Perez or other C-suite executives continue selling without derivative conversion offsets, it could signal reduced conviction at current valuation levels (~$55). The stock's recent volatility (T+20 alpha -0.55% historically on neutral calls) suggests limited immediate downside from this cluster alone.
Price Chart
Executive Summary
CEO Daniel Perez and Director Gabriel Mecklenburg sold a combined $5.25M of HNGE stock on May 6-7, 2026, immediately following the company's record Q1 earnings report (revenue +47% YoY, raised FY guidance). The sales were executed via pre-arranged 10b5-1 plans tied to derivative conversions, representing ~0.12% of market cap — a modest but notable cluster. The strong earnings and raised outlook provide a positive fundamental backdrop, but the CEO's $8.3M in total sales over two days warrants monitoring for any follow-on selling.
Key Financial Metrics
Key Facts
- CEO Daniel Perez sold 150,000 shares total ($8.26M) on May 6-7 via open-market sales after converting derivatives
- Director Gabriel Mecklenburg sold 50,000 shares ($2.75M) on May 6 after converting derivatives
- Total open-market sales in cluster: $11.01M (Perez $8.26M + Mecklenburg $2.75M)
- Sales occurred 1-2 days after Hinge Health reported record Q1 revenue of $182.3M (+47% YoY) and raised FY2026 revenue guidance to $801M midpoint
- Cluster value represents ~0.26% of HNGE's $4.3B market cap — modest but above routine threshold
- All sales were executed via pre-arranged 10b5-1 trading plans tied to derivative conversions (non-cash events)
- Recent 30-day insider activity shows $11.0M in total sales prior to this cluster
Financial Impact
Total insider sales of $11.01M represent 0.26% of market cap — modest but notable given CEO participation
Risk Factors
- CEO selling $8.3M within 48 hours of earnings may be perceived negatively by the market despite strong results
- Insider selling cluster could cap near-term upside if interpreted as insiders taking profits at peak valuation
- Pre-arranged 10b5-1 plans reduce signaling value but do not eliminate it entirely
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HNGE-1778545358115 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.73 $94.45 | ▲ +0.77% | ▼ −2.07% | $97.24 (+3.74%) |
Sep 14, 2026 17d ago | Insider Cluster | $92.39 $94.90 | ▲ +2.72% | ▲ +1.90% | $97.24 (+5.25%) |
Sep 11, 2026 20d ago | Insider Cluster | $94.79 $94.45 | ▲ +0.36% | ▲ +2.02% | $97.24 (−2.58%) |
Sep 1, 2026 4w ago | 144 | $91.85 $88.26 | ▼ −3.91% | ▼ −2.95% | $97.24 (+5.87%) |
Aug 20, 2026 6w ago | 144 | $88.42 $87.35 | ▼ −1.21% | ▼ −1.68% | $97.24 (+9.98%) |
Aug 4, 2026 8w ago | 8-K | $80.79 $86.32 | ▲ +6.84% | ▲ +6.49% | $97.24 (+20.36%) |
Jul 10, 2026 12w ago | Insider Cluster | $88.80 $85.98 | ▲ +3.18% | ▲ +2.62% | $97.24 (−9.50%) |
Jul 2, 2026 13w ago | Insider Cluster | $84.05 $89.92 | ▼ −6.98% | ▼ −6.05% | $97.24 (−15.69%) |
Jul 2, 2026 13w ago | Insider Cluster | $84.05 $89.92 | ▼ −6.98% | ▼ −6.05% | $97.24 (−15.69%) |
Jun 30, 2026 13w ago | Insider Cluster | $83.00 $88.52 | ▼ −6.65% | ▼ −6.05% | $97.24 (−17.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access